You are here

Home

Clinical Trials: Brain Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, May 6, 2021 - 12:00
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy
Conditions:   Multiple System Atrophy;   Parkinsonism;   Multiple System Atrophy, Parkinson Variant
Interventions:   Biological: Autologous Adipose Mesenchymal Stem Cell Implantation;   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation;   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation
Sponsor:   Indonesia University
Recruiting
Posted: Tuesday, March 23, 2021 - 12:00
Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke
Condition:   Ischemic Stroke
Interventions:   Biological: Umbilical Cord-derived Mesenchymal Stem Cells;   Drug: Placebo
Sponsor:   General Hospital of Shenyang Military Region
Recruiting
Posted: Tuesday, November 17, 2020 - 12:00
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
Condition:   Ischemic Stroke
Intervention:   Biological: Neural Stem Cells
Sponsor:   Gary Steinberg
Not yet recruiting
Posted: Thursday, October 29, 2020 - 12:00
A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogenic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR)
Condition:   Acute Ischemic Stroke
Interventions:   Biological: JTR-161;   Biological: Placebo
Sponsor:   Teijin Pharma Limited
Recruiting
Posted: Monday, October 19, 2020 - 12:00
Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)
Condition:   Ischemic Stroke
Interventions:   Drug: it-hMSC;   Drug: Placebo
Sponsors:   Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.;   Beijing Tiantan Hospital
Not yet recruiting
Posted: Monday, August 10, 2020 - 12:00
Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD
Condition:   Parkinson's Disease
Interventions:   Drug: MSC+placebo;   Drug: MSC;   Drug: Placebo
Sponsors:   The University of Texas Health Science Center, Houston;   Michael J. Fox Foundation for Parkinson's Research
Not yet recruiting
Posted: Tuesday, July 28, 2020 - 12:00
Study of the Therapeutic Effects of Cortical Autograft Implantation in Patients With Cerebral Ischemia
Condition:   Ischemic Stroke
Intervention:   Other: Autologous transplant
Sponsor:   Centre Hospitalier Universitaire Vaudois
Not yet recruiting
Posted: Wednesday, July 22, 2020 - 12:00
A Phase 2b Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease
Condition:   Alzheimer Disease
Interventions:   Drug: AstroStem and Donepezil Placebo;   Drug: Donepezil and AstroStem Placebo
Sponsor:   Nature Cell Co. Ltd.
Not yet recruiting
Posted: Wednesday, June 17, 2020 - 12:00
MyHand 2: An Active Hand Orthosis for Stroke Patients
Conditions:   Stroke;   Hemiparesis;Poststroke/CVA (Cerebrovascular Accident)
Intervention:   Device: MyHand Device
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting
Posted: Wednesday, June 17, 2020 - 12:00
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke
Condition:   Acute Stroke
Intervention:   Biological: UMSC01
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Recruiting

Pages